In the first such procedure, Vanderbilt University Medical Center has transplanted a DCD (donation after cardiac death) heart using XVIVO Heart Assist Transport (XHAT), a novel cold organ perfusion device.
The Vanderbilt Transplant Center established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.
A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.
For the second year, a delegation of doctors from Ukraine recently visited Vanderbilt University Medical Center to observe organ transplants and protocols.
Researchers at Vanderbilt are considering participation in an international study to examine if a blood-clotting medication given to adults with major bleeding or in need of urgent surgery or an invasive procedure can improve survival.
A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,
Accessibility Tools